Discovery Technologies
Immunization Strategies
Genovac’s core technology, genetic immunization, enables the development of antibodies against any protein target directly from DNA, an electronic sequence, or an accession number.
Find out more
Single B Cell Platforms
Genovac is the premier research partner offering multiple automated single B cell antibody discovery platforms for rare antibody discovery; Berkeley Lights’ Beacon single B cell screening and selection platform
Find out more
Advanced Hybridoma
Highly efficient semi-solid and well-based fusion options provide rapid delivery of antibodies that are comparable to yields of manual single B cell platforms.
Find out more
